The RealMoney contributors are in the business of trading and investing all day on the basis of ongoing news flow. Below, we offer the top five ideas that RealMoney contributors posted today and how they played those ideas.

TheStreet.com brings you the news all day, and with RealMoney's "Columnist Conversation," you can see how the pros are playing it on a real-time basis. Here are the top five ideas played today. To see all that RealMoney offers, click here for a free trial.

BMY and AMZN

By Jim Cramer
6:32 a.m. EDT

Both Bristol-Myers Squibb ( BMY) and Amazon ( AMZN) made great, additive acquisitions last night. If you have never been on Zappos, I'll tell you that it is the ultimate virtual department store. BMY needed growth and had cash that was doing nothing; this Medarex acquisition makes a growth change for them.

Positions: Long BMY


F5 Networks Cup and Handle

By Alan Farley
7:34 a.m. EDT

F5 Networks ( FFIV) is trading near $37 this morning, after a positive response to last night's earnings release. The stock has been hovering near its August 2008 high for the last six weeks and has now completed a bullish-looking cup-and-handle breakout pattern.

The top of the recent range is near $37.25, so it's still hard to tell if this morning's open will trigger a notable breakout or a range swing. Initial reward after a breakout is limited to $40 because a 2007 unfilled gap at that level is likely to attract selling pressure. Longer-term, the stock could finally test its all-time high, posted at $46.94 in July 2007.

Annotated chart here.

Positions: None


Double Dip?

By Robert Marcin
9:03 a.m. EDT

Joe Stiglitz highlighted the possibility of a double dip yesterday. I have talked about this for a while. The bulls think we have a normal recovery ahead, while the bears already count on another economic fade. I would rather bet on the bearish case, but I am not sure.

We do know that the economy is fragile. We also know that the consumer is getting slammed by declining wealth and rising employment insecurity. Therefore, we remain susceptible to any kind of negative surprise or shock.

The S&P has clawed its way back to 950, the October level of Warren Buffett's "Buy American" call. The next move depends on the fundamentals and how they break. Financials have been a tell for two years now, and they have rolled over on June earnings reports. The bank cheerleaders have put away their pom-poms. The bulls should be somewhat concerned by this.

If the economy continues to recover in a normal fashion, shares could grind higher. But if the economy continues to struggle, good chunks of the commodity and stock market might be ahead of things.


On Fertilizer

By Sham Gad
9:35 a.m. EDT

Potash ( POT) just released an earnings report that was below expectations. In addition, earnings forecasts for the remainder of the year have been lowered to between $4 and $5 a share for 2009, significantly below management's earlier guidance of $7 a share. The reaction of shares today could reveal a lot about whether the market still has a confident long-term view of fertilizer companies.

Personally, I am still bullish on the long-term fundamentals of fertilizer. I wrote a column earlier this week on urbanization and its long-term trends -- trends that look very favorable for fertilizer. It's a matter of when fertilizer comes back, not if. Besides the rumored $25 billion buyout of Mosaic ( MOS) last week, which got zero attention, Mosaic management reveals that today's prices are way too cheap. Those who are willing to accept the short-term volatility will likely benefit exceedingly well in 2010 and 2011. The July 10 issue of Grants Interest Rate Observer contained a very bullish article on Mosaic, citing the balance sheet.

Positions: Long MOS and POT


Bond Trading in Financials

By Tom Graff
10:05 a.m. EDT

In financials, PNC ( PNC), Fifth-Third ( FITB) and Huntington ( HBAN) all missed this morning. Only PNC has heavily traded debt among that group and is unchanged this morning. Other financials are 3 to 5 basis points tighter.

Capital One ( COF) is a big one to watch after the bell. After three regionals missed today, pressure on cards has to be on everyone's mind.

Positions: None


For free trial to Real Money, where you can get updated trading and investment ideas throughout the course of the day, please click on the tile below.

This article was written by a staff member of RealMoney.com.

If you liked this article you might like

3 Reasons Pfizer May Want to Buy Bristol-Myers Squibb

3 Reasons Pfizer May Want to Buy Bristol-Myers Squibb

Bristol-Myers 'Is Back' and Could Soar Another 14%

Bristol-Myers 'Is Back' and Could Soar Another 14%

These Were the 3 Hottest Stories on Wall Street Thursday

These Were the 3 Hottest Stories on Wall Street Thursday

Rock and Roll: Bristol-Myers Squibb Is Breaking Out

Rock and Roll: Bristol-Myers Squibb Is Breaking Out

Dow Soars Over 250 Points to Post Its Fourth Straight Day of Gains